Viewing nowCombinationDonggu Zaltan Jeng 5/50mg (Amlodipine Besylate, Losartan Potassium)
Amlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 201502701 · Approved 2015.04.30
Treatment of essential hypertension not controlled with monotherapy; initial treatment of Stage II hypertension
This medication is beneficial for patients with essential hypertension who find it difficult to control blood pressure with amlodipine or losartan alone. It is also used in initial treatment for Stage 2 hypertension patients who need combination therapy to reach the target blood pressure. This effectively manages blood pressure and improves health.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using an individual component as follows, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should be based on factors such as baseline blood pressure, target blood pressure, and the expected degree of attainment of the treatment goal with the combination product compared with the individual products. Usually, this medicine is administered at 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: Administration of this medicine is not recommended in a small number of patients with reduced effective intravascular volume (e.g., patients being treated with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Various serious side effects can occur, including reduced fetal kidney function, hypotension, and craniosynostosis, so it should not be used during pregnancy. If a pregnant woman needs to take this medication, she must be fully informed of the risks to the fetus, and the fetal condition should be closely monitored through regular ultrasound examinations. Patients with decreased intravascular effective blood volume, such as those on diuretics, may experience hypotension when first prescribed this medication, so caution is necessary. Patients with hypersensitivity to the components of this medication, pregnant and lactating women, those with severe liver impairment, severe aortic stenosis, and those in shock should not be administered this medication. Caution should be exercised when prescribing to patients with decreased intravascular effective blood volume, those on strict salt restrictions, moderate to severe renal impairment, and those with hyperkalemia. Side effects such as dizziness, headache, drowsiness, palpitations, orthostatic hypotension, skin rash may occur, and any abnormal symptoms should be reported to a healthcare professional immediately. When operating hazardous machinery, such as driving or working at heights, caution is necessary due to the risk of accidents from symptoms like dizziness. Patients with impaired liver or kidney function should consult healthcare professionals before taking this medication, and dosage adjustments may be necessary. When used in conjunction with potassium-sparing diuretics or potassium supplements, blood potassium levels may increase, so potassium levels should be monitored regularly. When used with other antihypertensive medications, potentiation of blood pressure-lowering effects may occur, requiring caution in administration. This medication is not recommended for children under 18 years of age due to a lack of established safety and efficacy. In elderly patients, especially those over 75 years of age, it is recommended not to initiate with this medication without guidance from a healthcare professional. Overdose may result in severe hypotension and tachycardia, and emergency treatment is necessary if symptoms are severe. Store out of reach of children, and do not transfer to other containers as it may affect product quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a sealed container. Additionally, it is advisable to keep this medication at room temperature between 1°C and 30°C. Avoid excessively hot or cold places and store in a cool place away from direct sunlight.
White, oblong, film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Huwons Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationAmlodipine Besylate 13.888mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.